Healthcare professionals' perceptions on the use of opioid analgesics for the treatment of cancer-related pain in Cyprus: A mixed-method study

Andreas Charalambous, Marios Zorpas, Constantina Cloconi, Yolanda Kading, Andreas Charalambous, Marios Zorpas, Constantina Cloconi, Yolanda Kading

Abstract

Objectives: Pain is considered the most common and debilitating symptom reported by patients affected by cancer, and opioids are at the front line for its effective management. However, the appropriate use of opioids can be limited by healthcare professionals' perceptions on opioids. Therefore, the aim of this study was to explore their perceptions on the use of opioids medication.

Methods: This was a study of sequential mixed-method design conducted in Cyprus. As part of the quantitative phase of the study, the Barriers to Opioid Analgesic Availability Test questionnaire was completed by 73 physicians randomly selected. In the qualitative phase, 28 healthcare professionals working in primary and secondary healthcare centers participated in two focus groups. They were asked to express their perceptions on the use of opioid analgesics for the treatment of cancer-related pain. Data were analyzed according to Colaizzis' seven-stage phenomenological analysis.

Results: The quantitative analysis showed that 69.85% of physicians acknowledge opiophobia as a main barrier to appropriate pain relief but also explicitly for cancer pain which is not adequately managed (45.19%). In terms of opioids availability, physicians stated that moderate to severe problems in opioids availability were mainly caused by their reluctance to prescribe opioids (49.3%) followed by the laws/regulations in place (41.08%). The qualitative analysis yielded the following six main themes: inadequate training of healthcare professionals in the use of opioid analgesics, inadequate patient/caregivers' awareness of opioid analgesics, opiophobia in healthcare professionals, opiophobia of patients/caregivers, poor management of opioid analgesics by healthcare professionals and patients/caregivers, and ineffective pain relief with opioids.

Conclusions: The lack of appropriate education is a significant barrier to opioids use in Cyprus. This is compounded by the attitudes and phobias of both healthcare professionals and the general public. In addition, there are barriers to opioid availability and unsatisfactory cancer pain relief.

Keywords: Opioids; healthcare professionals; pain management; perception.

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Opiophobia model.
Figure 2.
Figure 2.
Proportion of responses relating to HIV/AIDS pain (n = 73).
Figure 3.
Figure 3.
Proportion of responses relating to other types of pain (n = 73).
Figure 4.
Figure 4.
Proportion of responses relating to cancer pain.

References

    1. International Association for the Study of Pain. IASP taxonomy, (accessed 18 January 2019).
    1. Henschke N, Kamper SJ, Maher CG. The epidemiology and economic consequences of pain. Mayo Clin Proc 2015; 90(1): 139–147.
    1. Campbell JN. APS 1995 presidential address. Pain Forum 1996; 1(5): 85–88.
    1. World Health Organization. International Classification of Diseases, 11th Revision, (accessed 18 January 2019).
    1. Morgan JP. American opiophobia: customary underutilization of opioid analgesics. Adv Alcohol Subst Abuse 1985; 5(1–2): 163–173.
    1. Zenz M, Willweber-Strumpf A. Opiophobia and cancer pain in Europe. Lancet 1993; 341(8852): 1075–1076.
    1. Todd A, Akhter N, Cairns J, et al. The Pain Divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England. BMJ Open 2018; 8(7): e023391.
    1. World Health Organization. Cancer pain relief. Geneva: World Health Organization, 1986.
    1. Jones MR, Viswanath O, Peck J, et al. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther 2018; 7(1): 13–21.
    1. Maxwell JC. The prescription drug epidemic in the United States: a perfect storm. Drug Alcohol Rev 2011; 30(3): 264–270.
    1. European Commission. Communication from the commission to the European parliament and the council parliament and the council,
    1. The Joint Commission. Pain management standards—hospital, (accessed 22 January 2019).
    1. Tick H, Nielsen A, Pelletier KR, et al. Evidence-based non-pharmacologic strategies for comprehensive pain care: the Consortium Pain Task Force white paper. Explore (NY) 2018; 14(3): 177–211.
    1. Breivik H, Eisenberg E, O’Brien T. The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health 2013; 13: 1229.
    1. O’Brien T, Christrup LL, Drewes AM, et al. European Pain Federation position paper on appropriate opioid use in chronic pain management. Eur J Pain 2017; 21(1): 3–19.
    1. Breuer B, Chang VT, Von Roenn JH, et al. How well do medical oncologists manage chronic cancer pain (CP)? A national survey. Oncologist 2015; 20(2): 202–209.
    1. Manjiani D, Paul DB, Kunnumpurath S, et al. Availability and utilization of opioids for pain management: global issues. Ochsner J 2014; 14(2): 208–215
    1. Shosha G. Employment of Colaizzi’s strategy in descriptive phenomenology: a reflection of a researcher. Eur Sci J 2012; 8(27): 31–43.
    1. Onishi E, Kobayashi T, Dexter E, et al. Comparison of opioid prescribing patterns in the United States and Japan: primary care physicians’ attitudes and perceptions. J Am Board Fam Med 2017; 30(2): 248–254.
    1. Greene J, Hibbard J, Alvarez C, et al. Supporting patient behavior change: approaches used by primary care clinicians whose patients’ activation levels increased. Ann Fam Med 2016; 14(2): 148–154.
    1. Hero JO, McMurtry C, Benson J, et al. Discussing opioid risks with patients to reduce misuse and abuse: evidence from 2 surveys. Ann Fam Med 2016; 14(6): 575–577.
    1. Dineen KK, Du Bois JM. Between a rock and a hard place: can physicians prescribe opioids to treat pain adequately while avoiding legal sanction? Am J Law Med 2016; 42(1): 7–52.
    1. Wolfert MZ, Gilson AM, Dahl JL, et al. Opioid analgesics for pain control: Wisconsin physicians’ knowledge, beliefs, attitudes, and prescribing practices. Pain Med 2010; 11(3): 425–434.
    1. Elcigil A, Maltepe H, Eşrefgil G, et al. Nurses’ perceived barriers to assessment and management of pain in a university hospital. J Pediatr Hematol Oncol 2011; 33(Suppl. 1): 33–38.
    1. Stumbo SP, Yarborough BJH, McCarty D, et al. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement. J Subst Abuse Treat 2017; 73: 47–54.
    1. Geppetti P, Benemei S. Pain treatment with opioids: achieving the minimal effective and the minimal interacting dose. Clin Drug Investig 2009; 29(Suppl. 1): 3–16.
    1. Mitra R, Jones S. Adjuvant analgesics in cancer pain: a review. Am J Hosp Palliat Care 2012; 29(1): 70–79.
    1. Drewes AM, Munkholm P, Simren M, et al. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction—Recommendations of the Nordic Working Group. Scand J Pain 2016; 11: 111–122.
    1. Booth C. In: Kinney J, Haapala D, Booth C. (eds) Keeping families together: the homebuilders model. London; New York: Routledge, 2017, p. 13.
    1. Upshur CC, Luckmann RS, Savageau JA. Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med 2006; 21(6): 652–655.
    1. Zuccaro SM, Vellucci R, Sarzi-Puttini P, et al. Barriers to pain management: focus on opioid therapy. Clin Drug Investig 2012; 32(Suppl. 1): 11–19.
    1. Maurer MA, Gilson AM, Husain SA, et al. Examining influences on the availability of and access to opioids for pain management and palliative care. J Pain Palliat Care Pharmacother 2013; 27(3): 255–260.
    1. Joranson DE, Ryan KM, Maurer M. Opioid policy, availability, and access in developing and non-industrialized countries. In: Fishman SM, Ballantyne JC, Rathmell JP. (eds) Bonica’s management of pain. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2010, pp. 194–208.
    1. Kwon JH. Overcoming barriers in cancer pain management. J Clin Oncol 2014; 32(16): 1727–1733.
    1. Dequeker S, Van Lancker A, Van Hecke A. Hospitalized patients’ vs. nurses’ assessments of pain intensity and barriers to pain management. J Adv Nurs 2018; 74(1): 160–171.
    1. Mularski RA, White-Chu F, Overbay D, et al. Measuring pain as the 5th vital sign does not improve quality of pain management. J Gen Intern Med 2006; 21(6): 607–612.
    1. Levy N, Sturgess J, Mills P. “Pain as the fifth vital sign” and dependence on the “numerical pain scale” is being abandoned in the US: why? Br J Anaesth 2018; 120(3): 435–438.
    1. Deldar K, Froutan R, Ebadi A. Challenges faced by nurses in using pain assessment scale in patients unable to communicate: a qualitative study. BMC Nurs 2018; 17: 11–18.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner